What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News CEL-SCI advances Multikine study with FDA nod, eyes non-dilutive funding for commercial push CEL-SCI Corporation has taken a significant step toward commercializing its investigational Multikine neoadjuvant therapy, as the U.S. Food… byPallavi MadhirajuMarch 17, 2025